Mizuho Senior Biotech Analyst Salim Syed shares his take on biotech's current lull, and discusses companies he covers
He comments on Arcus, Vaxcyte, Cytokinetics, BridgeBio, Maze Therapeutics, and Century Therapeutics.
Chapters
General sentiment - 1:37
Arcus - 3:49
Vaxcyte - 6:40
Cytokinetics - 10:30
BridgeBio - 14:48
Maze Therapeutics - 17:40
Century Therapeutics - 19:47









.png)